Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis;Évaluation de la qualité de vie par le MOS-SF36 dans la sclérodermie systémique

Revue de Medecine Interne

Volumn 25, Issue 1, 2004, Pages 16-21

  Georges, C ^a   Chassany, O ^a   Mouthon, L ^b   Tiev, K ^c   Marjanovic, Z ^a   Meyer, O ^d   Toledano, C ^a   Ilie, D ^a   Guillevin, L ^b   Sereni, D ^a   Cabane, J ^c   Farge, D ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b AVICENNE HOSPITAL   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d BICHAT HOSPITAL   (France)

Author keywords

Quality of life; Scleroderma; SF 36; Systemic sclerosis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL OUTCOME STUDY SHORT FORM 36; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; SYSTEMIC SCLEROSIS; VALIDATION PROCESS; ADOLESCENT; CROSS-SECTIONAL STUDY; MIDDLE AGED; SICKNESS IMPACT PROFILE;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SCLERODERMA, SYSTEMIC; SICKNESS IMPACT PROFILE;

EID: 10744227100     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(03)00268-6     Document Type: Article

References (16)

1. Fries J.F., Spitz P.W., Young D.Y. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol. 9:1982;789-793.
2. Steen V.D., Medsger T.A. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum. 40:1997;1984-1991.
3. Stoll T., Gordon C., Seifert B., Richardson K., Malik J., Bacon P.A., et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol. 24:1997;1608-1614.
4. Wang C., Mayo N.E., Fortin P.R. The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol. 28:2001;525-532.
5. Talamo J., Frater A., Gallivan S., Young A. Use of the short for health status measurement in rheumatoid arthritis. Br J Rheumatol. 36:1997;463-469.
6. Juenger J., Schellberg D., Kraemer S., Haunstetter A., Zugck C., Herzog W., et al. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart. 87:2002;235-241.
7. Malher D.A., Mackowiak J.I. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest. 107:1995;1585-1589.
8. Chassany O., Marquis P., Scherrer B., Read N.W., Finger T., Bergmann J.F., et al. Validation of a Specific Quality of Life Questionnaire in Functional Digestive Disorders (FDDQL). Gut. 44:1999;527-533.
9. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 23:1980;581-590.
10. LeRoy E.C., Medsger T.A. Jr. Criteria for the classification of early sclerosis. J Rheumatol. 28:2001;1573-1576.
11. Ware J.E. Jr. SF-36 Health Survey: Manual and Interpretation Guide. 1993;Health Institute, New England Medical Center, Boston.
12. Leplège A., Ecosse E., Verdier A., Perneger T.V. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 51:1998;1013-1023.
13. Poole J.L., Steen V.D. The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res. 4:1991;27-31.
14. Medsger T., Silman A., Steen V., Black C., Akesson A., Bacon P., et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol. 26:1999;2159-2167.
15. Clements Ph., Lachenbruch P., Siebold J., White B., Wiener S., Martin R., et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J. Rheumatol. 22:1995;1281-1285.
16. Farge D., Marolleau J.P., Zohar S., Marjanovic Z., Cabane J., Mounier N., et al. Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis. Br J Haematol. 119:2002;729-739.